Assessing the role of ultrasound in predicting the biological behavior of breast cancer

American Journal of Roentgenology

Volumn 200, Issue 2, 2013, Pages 284-290

  Irshad, Abid ^a   Leddy, Rebecca ^a   Pisano, Etta ^a   Baker, Nathaniel ^b   Lewis, Madelene ^a   Ackerman, Susan ^a   Campbell, Amy ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Breast cancer; Estrogen receptor; Progesterone receptor; Triple negative tumor; Ultrasound

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ACCURACY; ADULT; AREA UNDER THE CURVE; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; ECHOMAMMOGRAPHY; ER GENE; ERRB2 GENE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PR GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, MAMMARY;

EID: 84873601304     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.8781     Document Type: Review

References (34)

1. Dent R, Trudeau M, Pritchard KI, et al. Triple negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13:4429-4434
2. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492-2502
3. Mersin H, Yildirim E, Berberoglu U, et al. The prognostic importance of triple negative breast carcinoma. Breast 2008; 17:341-346
4. Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer 2007; 109:25-32
5. Rodríguez-Pinilla SM, Sarrio D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 2006; 12:1533-1539
6. Rodríguez-Pinilla SM, Sarrio D, Honrado E, et al. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol 2007; 60:1006-1012
7. American College of Radiology. Breast imaging reporting and data system, (BI-RADS), 4th ed. Reston, VA: American College of Radiology, 2003
8. Ko ES, Lee B, Kim H, et al. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 2010; 20:1111-1117
9. Dogan BE, Gonzalez-Angulo A, Gilcrease M, Dryden MJ, Yang WT. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR 2010; 194:1160-1166
10. Kojima Y, Tsunoda H. Mammography and ultrasound features of triple-negative breast cancer. Breast Cancer 2011; 18:146-151
11. Kim SH, Seo B, Lee J, et al. Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta Oncol 2008; 47:1531-1538
12. Basu S, Chen W, Tchou J, et al. Comparison of triplenegative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer 2008; 112:995-1000
13. Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 2009; 250:638-647
14. Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 2008; 246:58-70
15. Yang WT, Tse GM. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR 2004; 182:101-110
16. Shin HJ, Kim HH, Kim SM, Kwon GY, Gong G, Cho OK. Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features. AJR 2008; 190:516-525
17. Kim JH, Ko ES, Kim DY, et al. Noncalcified ductal carcinoma in situ: imaging and histologic findings in 36 tumors. J Ultrasound Med 2009; 28:903-910
18. Yang WT, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 2008; 111:405-410
19. Wang Y, Ikeda DM, Narasimhan B, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology 2008; 246:367-375
20. Rakha EA, Reis-Filho JS, Baehner F, et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 2010; 12:207
21. Rakha EA, Reis-Filho JS, Ellis IO, et al. Basallike breast cancer: a critical review. J Clin Oncol 2008; 26:2568-2581
22. Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology 2008; 52:108-118
23. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-752
24. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869-10874
25. Sørlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100:8418-8423
26. Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7:96
27. Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27:1160-1167
28. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004; 10:5367-5374
29. Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008; 14:1368-1376
30. Fulford LG, Reis-Filho JS, Ryder K, et al. Basallike grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res 2007; 9:R4
31. Rakha E, Ellis I, Reis-Filho J. Are triple-negative and basal-like breast cancer synonymous? (letter and reply) Clin Cancer Res 2008; 14:618-619
32. Rakha EA, El-Sayed ME, Lee AH, et al. Prognosticsignificance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 2008; 26:3153-3158
33. Walker RA. The complexities of breast cancer desmoplasia. Breast Cancer Res 2001; 3:143-145
34. Bronzert DA, Pantazis P, Antoniades HN, et al. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA 1987; 84:5763-5767